Greater Cannabis Company (GCAN) Acquisitions (2020)
Greater Cannabis Company's (GCAN) quarterly Acquisitions came in at $25000.0 in Q1 2020.
Greater Cannabis Company (GCAN) Acquisitions (2020) Analysis & Trends
Greater Cannabis Company's Acquisitions history runs 1 years deep, the most recent figure standing at $25000.0 for Q1 2020.
- On a quarterly basis, Acquisitions changed N/A year-over-year to $25000.0 in Q1 2020; TTM through Dec 2020 was $25000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $25000.0, changed N/A from the prior year.
- Acquisitions was little changed at $25000.0 in Q1 2020 per GCAN's latest filing.
- Across five years, Acquisitions topped out at $25000.0 in Q1 2020 and bottomed at $25000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 25,000.00 |